• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急诊科缓激肽诱导的血管性水肿与组胺诱导的血管性水肿的综合综述

A Comprehensive Review of Bradykinin-Induced Angioedema Versus Histamine-Induced Angioedema in the Emergency Department.

作者信息

Jayasinghe Maleesha, Caldera Dilushini, Prathiraja Omesh, Jena Rahul, Coffie-Pierre James Anwar, Agyei James, Silva Minollie Suzanne, Kayani Abdul Mueez Alam, Siddiqui Ozair S

机构信息

Medicine, Nanjing Medical University, Nanjing, CHN.

Internal Medicine, Nanjing Medical University, Nanjing, CHN.

出版信息

Cureus. 2022 Nov 30;14(11):e32075. doi: 10.7759/cureus.32075. eCollection 2022 Nov.

DOI:10.7759/cureus.32075
PMID:36600855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9803396/
Abstract

Angioedema (AE) is a condition that is frequently encountered in the emergency department (ED). It is a rare condition with localized, asymmetrical swelling of the skin and/or mucosa that is frequently nonpruritic and primarily affects locations with loose connective tissue. Physicians must have a thorough understanding of this condition since it can cause fatal airway compromise, which might be the presenting symptom. Histamine-mediated AE is the most common type of AE seen in EDs. However, ED physicians must be on the lookout for the less common bradykinin-mediated types of AE as these do not respond to the same therapy as histamine-mediated AE. Hospitals may lack specialized drugs or protocols, and many ED staff may be unable to identify or treat bradykinin-mediated AE. It is crucial to understand the pathophysiology of the various kinds of AE in order to optimize treatment. The goal of this review paper is to provide an overview of the pathophysiology, clinical manifestations, and treatment options for bradykinin and histamine-induced AE in the ED.

摘要

血管性水肿(AE)是急诊科(ED)经常遇到的一种病症。它是一种罕见的病症,表现为皮肤和/或黏膜局部、不对称性肿胀,通常无瘙痒感,主要影响疏松结缔组织所在部位。由于它可能导致致命的气道梗阻,而这可能是首发症状,因此医生必须对这种病症有透彻的了解。组胺介导的AE是急诊科中最常见的AE类型。然而,急诊科医生必须留意较少见的缓激肽介导的AE类型,因为这些类型对组胺介导的AE的治疗方法没有反应。医院可能缺乏专门的药物或方案,许多急诊科工作人员可能无法识别或治疗缓激肽介导的AE。了解各种AE的病理生理学对于优化治疗至关重要。这篇综述文章的目的是概述急诊科中缓激肽和组胺诱导的AE的病理生理学、临床表现及治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b453/9803396/17d78221d781/cureus-0014-00000032075-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b453/9803396/234c3d3aed7f/cureus-0014-00000032075-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b453/9803396/efcfe7421104/cureus-0014-00000032075-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b453/9803396/d3ca14717edc/cureus-0014-00000032075-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b453/9803396/17d78221d781/cureus-0014-00000032075-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b453/9803396/234c3d3aed7f/cureus-0014-00000032075-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b453/9803396/efcfe7421104/cureus-0014-00000032075-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b453/9803396/d3ca14717edc/cureus-0014-00000032075-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b453/9803396/17d78221d781/cureus-0014-00000032075-i04.jpg

相似文献

1
A Comprehensive Review of Bradykinin-Induced Angioedema Versus Histamine-Induced Angioedema in the Emergency Department.急诊科缓激肽诱导的血管性水肿与组胺诱导的血管性水肿的综合综述
Cureus. 2022 Nov 30;14(11):e32075. doi: 10.7759/cureus.32075. eCollection 2022 Nov.
2
Recognition and Differential Diagnosis of Hereditary Angioedema in the Emergency Department.急诊科遗传性血管性水肿的识别与鉴别诊断。
J Emerg Med. 2021 Jan;60(1):35-43. doi: 10.1016/j.jemermed.2020.09.044. Epub 2020 Nov 17.
3
Angioedema in the emergency department: a practical guide to differential diagnosis and management.急诊科血管性水肿:鉴别诊断与管理实用指南
Int J Emerg Med. 2017 Dec;10(1):15. doi: 10.1186/s12245-017-0141-z. Epub 2017 Apr 13.
4
Management of angioedema without urticaria in the emergency department.急诊科中无荨麻疹的血管性水肿的管理
Ann Med. 2014 Dec;46(8):607-18. doi: 10.3109/07853890.2014.949300.
5
Bradykinin-induced angioedema in the emergency department.急诊科中缓激肽诱导的血管性水肿
Int J Emerg Med. 2022 Mar 26;15(1):15. doi: 10.1186/s12245-022-00408-6.
6
Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedema.鉴定新型生物标志物以区分缓激肽介导的血管性水肿与肥大细胞/组胺介导的血管性水肿。
Allergy. 2022 Mar;77(3):946-955. doi: 10.1111/all.15013. Epub 2021 Jul 28.
7
Consequences of Misdiagnosed and Mismanaged Hereditary Angioedema Laryngeal Attacks: An Overview of Cases from the Romanian Registry.遗传性血管性水肿喉发作误诊和管理不当的后果:罗马尼亚登记处病例概述
Case Rep Emerg Med. 2018 Oct 22;2018:6363787. doi: 10.1155/2018/6363787. eCollection 2018.
8
Recurrent angioedema: diagnosis strategy and biological aspects.复发性血管性水肿:诊断策略与生物学方面
Eur J Dermatol. 2014 May-Jun;24(3):293-6. doi: 10.1684/ejd.2014.2276.
9
The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.依卡替班(一种B2缓激肽受体拮抗剂)在急诊科危及生命的喉血管性水肿中的作用。
Am J Emerg Med. 2015 Mar;33(3):479.e1-3. doi: 10.1016/j.ajem.2014.08.055. Epub 2014 Aug 27.
10
[The ulm emergency algorithm for the acute treatment of drug-induced, bradykinin-mediated angioedema].[用于药物诱导的、缓激肽介导的血管性水肿急性治疗的乌尔姆急救算法]
Med Klin Intensivmed Notfmed. 2019 Nov;114(8):708-716. doi: 10.1007/s00063-018-0483-1. Epub 2018 Sep 19.

引用本文的文献

1
Impact of providing education on the recognition and differential diagnosis of angioedema among emergency department physicians.为急诊科医生提供血管性水肿识别与鉴别诊断教育的影响。
World Allergy Organ J. 2025 Aug 9;18(8):101101. doi: 10.1016/j.waojou.2025.101101. eCollection 2025 Aug.
2
Adaptation and Linguistic Validation of Angioedema PROMs in Latvian for Assessing Recurrent Angioedema.用于评估复发性血管性水肿的拉脱维亚语血管性水肿患者报告结局量表的改编与语言验证
J Clin Med. 2025 Feb 19;14(4):1375. doi: 10.3390/jcm14041375.
3
Activation of the Coagulation Cascade as a Universal Danger Sign.

本文引用的文献

1
Longitudinal experience with treatment of acquired angioedema using tranexamic acid.使用氨甲环酸治疗获得性血管性水肿的纵向经验。
Allergy Asthma Proc. 2022 Sep 1;43(5):413-418. doi: 10.2500/aap.2022.43.220043.
2
Bradykinin-induced angioedema in the emergency department.急诊科中缓激肽诱导的血管性水肿
Int J Emerg Med. 2022 Mar 26;15(1):15. doi: 10.1186/s12245-022-00408-6.
3
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update.《遗传性血管性水肿管理的国际 WAO/EAACI 指南-2021 年修订版》。
凝血级联反应的激活作为一种普遍的危险信号。
Curr Issues Mol Biol. 2025 Feb 9;47(2):108. doi: 10.3390/cimb47020108.
4
Escin's Action on Bradykinin Pathway: Advantageous Clinical Properties for an Unknown Mechanism?七叶皂苷对缓激肽途径的作用:未知机制下的有利临床特性?
Antioxidants (Basel). 2024 Sep 19;13(9):1130. doi: 10.3390/antiox13091130.
5
Dabsylated Bradykinin Is Cleaved by Snake Venom Proteases from .来自……的蛇毒蛋白酶可切割二甲基丙烯酰化缓激肽
Biomedicines. 2024 May 7;12(5):1027. doi: 10.3390/biomedicines12051027.
6
Pathophysiology of bradykinin and histamine mediated angioedema.缓激肽和组胺介导的血管性水肿的病理生理学
Front Allergy. 2023 Oct 18;4:1263432. doi: 10.3389/falgy.2023.1263432. eCollection 2023.
7
Extensive Soft Tissue Swelling in the Larynx and Hypopharynx of a Young Female Patient After Haloperidol Use: A Case Report on Angioneurotic Edema.使用氟哌啶醇后年轻女性患者喉和下咽广泛软组织肿胀:一例血管性水肿病例报告
Cureus. 2023 Jul 11;15(7):e41684. doi: 10.7759/cureus.41684. eCollection 2023 Jul.
Allergy. 2022 Jul;77(7):1961-1990. doi: 10.1111/all.15214. Epub 2022 Feb 3.
4
Managing Chronic Urticaria and Recurrent Angioedema Differently with Advancing Age.随着年龄的增长,慢性荨麻疹和复发性血管性水肿的管理方式也不同。
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2186-2194. doi: 10.1016/j.jaip.2021.03.034. Epub 2021 Apr 2.
5
Angioedema without wheals: a clinical update.无风团性血管性水肿:临床更新。
Balkan Med J. 2021 Mar;38(2):73-81. doi: 10.5152/balkanmedj.2021.20060.
6
Kinin B1 receptor: A target for neuroinflammation in hypertension.激肽 B1 受体:高血压神经炎症的靶点。
Pharmacol Res. 2020 May;155:104715. doi: 10.1016/j.phrs.2020.104715. Epub 2020 Feb 19.
7
Hereditary and acquired angioedema.遗传性血管性水肿和获得性血管性水肿。
Allergy Asthma Proc. 2019 Nov 1;40(6):441-445. doi: 10.2500/aap.2019.40.4267.
8
Evaluation and Management of Angioedema in the Emergency Department.急诊科血管性水肿的评估与管理。
West J Emerg Med. 2019 Jul;20(4):587-600. doi: 10.5811/westjem.2019.5.42650. Epub 2019 Jul 2.
9
Angioedema and emergency medicine: From pathophysiology to diagnosis and treatment.血管性水肿与急诊医学:从病理生理学到诊断与治疗。
Eur J Intern Med. 2019 Jan;59:8-13. doi: 10.1016/j.ejim.2018.09.004. Epub 2018 Sep 13.
10
Histaminergic Angioedema.组胺能性血管性水肿
Immunol Allergy Clin North Am. 2017 Aug;37(3):467-481. doi: 10.1016/j.iac.2017.03.001. Epub 2017 May 13.